Myths vs facts: VDR and menopause

The question about myths vs facts regarding VDR (vitamin D receptor) and menopause cannot be directly answered from the provided context, which lacks specific information on VDR or menopause. In general: VDR mediates the genomic actions of vitamin D and is involved in calcium homeostasis and immune modulation. A common myth is that certain VDR variants (e.g., rs2228570) determine the severity of menopausal symptoms like hot flashes or bone loss. In reality, studies show only weak, inconsistent associations. The evidence is mostly mechanistic or from small observational studies. Another myth is that vitamin D supplementation can be personalized for menopause based solely on VDR genotype. No robust randomized controlled trials support this. Fact: vitamin D deficiency is common during menopause and should be corrected clinically, but VDR genotyping currently has no proven value for individual treatment decisions. Caveat: No direct sources in the provided context; statements are based on general scientific knowledge. Evidence is rated as 'unclear'.